MedPath

Cross-Training and Locomotor Abilities in Cerebral Palsy

Not Applicable
Completed
Conditions
Cerebral Palsy (CP)
Spastic Hemiparesis
Registration Number
NCT06750081
Lead Sponsor
Cairo University
Brief Summary

The purpose was to investigate the effect of cross-training as a method of unilateral motor priming on locomotor abilities in children with spastic unilateral cerebral palsy.

Detailed Description

Thirty children with spastic unilateral cerebral palsy were recruited from different rehabilitation centers. They were assigned randomly into two groups. Children in the control group (A) were engaged in a selected physical therapy program while those in the experimental group (B) received cross-training program followed by application of the same selected physical therapy program received by group (A). The treatment programs were conducted five times per week for six successive weeks. Measurements obtained included active ankle dorsiflexion range of motion (AROM), and the speed of walking obtained by 10-meter walking test. These measures were recorded two times: pre- and post-treatment.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
40
Inclusion Criteria
  • Spasticity grade 1 to 1+, according to the Modified Ashworth Scale.
  • Can stand and walk autonomously.
  • Able to follow verbal commands and instructions.
Exclusion Criteria
  • Fixed musculoskeletal deformities
  • significant cognitive disorders
  • significant perceptual disorders
  • significant auditory disorders
  • significant visual disorders

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Primary Outcome Measures
NameTimeMethod
active ankle dorsiflexion range of motion (AROM)Baseline and at the end - through study completion, an average of 1 year
10-meter walking testBaseline and at the end - through study completion, an average of 1 year
Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

Faculty of Physical Therapy, Cairo University

🇪🇬

Giza, Cairo, Egypt

© Copyright 2025. All Rights Reserved by MedPath